Financial Performance - The company's operating revenue for Q1 2023 was CNY 1,352,672,296.69, representing a decrease of 50.25% compared to the same period last year[5]. - The net profit attributable to shareholders for Q1 2023 was CNY 123,637,564.73, down 80.86% year-on-year[5]. - The basic earnings per share for Q1 2023 was CNY 0.4163, reflecting an 80.86% decline compared to the previous year[6]. - Total operating revenue for Q1 2023 was ¥1,352,672,296.69, a decrease of 50.2% compared to ¥2,719,079,434.12 in Q1 2022[17]. - Net profit for Q1 2023 was ¥123,622,745.10, a decline of 81.0% compared to ¥651,775,603.73 in Q1 2022[18]. - Total comprehensive income for Q1 2023 was CNY 123,727,009.64, compared to CNY 651,792,919.22 in Q1 2022, indicating a significant decline[19]. - Basic and diluted earnings per share for Q1 2023 were CNY 0.4163, down from CNY 2.1745 in Q1 2022, reflecting a decrease of approximately 81.1%[19]. Cash Flow - The net cash flow from operating activities was CNY 96,813,722.53, a decrease of 72.23% year-on-year[5]. - Net cash flow from operating activities for Q1 2023 was CNY 96,813,722.53, a decrease of 72.8% from CNY 348,590,406.32 in Q1 2022[21]. - Cash inflow from operating activities totaled CNY 1,604,330,193.99 in Q1 2023, down 26.4% from CNY 2,180,216,077.52 in Q1 2022[20]. - Cash outflow from operating activities was CNY 1,507,516,471.46 in Q1 2023, compared to CNY 1,831,625,671.20 in Q1 2022, a decrease of 17.7%[21]. - Net cash flow from investing activities was -CNY 72,697,403.51 in Q1 2023, an improvement from -CNY 401,754,111.30 in Q1 2022[21]. - Net cash flow from financing activities was -CNY 5,753,101.18 in Q1 2023, compared to CNY 20,461,158.32 in Q1 2022, indicating a decrease in cash outflow[21]. - The ending balance of cash and cash equivalents as of March 31, 2023, was CNY 1,945,279,239.01, up from CNY 1,069,685,675.28 at the end of Q1 2022[21]. Assets and Liabilities - Total assets at the end of Q1 2023 were CNY 6,142,198,492.04, down 5.69% from the end of the previous year[6]. - The company's total assets decreased to ¥6,142,198,492.04 in Q1 2023 from ¥6,513,098,085.61 in Q1 2022, reflecting a reduction of 5.7%[16]. - Total liabilities decreased to ¥2,676,337,349.00 in Q1 2023 from ¥3,200,728,965.79 in Q1 2022, a decline of 16.3%[15]. - Total non-current liabilities amounted to approximately 830.27 million, with long-term borrowings at 602.46 million[26]. - Total liabilities reached approximately 3.20 billion, reflecting a slight decrease of 1.06 million compared to the previous period[26]. - The total liabilities and equity combined were approximately 6.51 billion, consistent with the company's financial strategy[26]. Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 22,180[10]. - The top shareholder, Nantong Industrial Holding Group Co., Ltd., holds 28.17% of the shares[10]. - The equity attributable to shareholders increased by 4.64% to CNY 3,463,093,571.42 compared to the end of the previous year[6]. - The company's equity attributable to shareholders increased to ¥3,463,093,571.42 in Q1 2023 from ¥3,309,586,728.58 in Q1 2022, an increase of 4.6%[16]. - The total equity attributable to shareholders was approximately 3.31 billion, with retained earnings at approximately 2.34 billion[26]. - The company reported a slight increase in undistributed profits by approximately 69.29 thousand, reaching 2.34 billion[26]. Research and Development - Research and development expenses for Q1 2023 were ¥42,249,446.03, down 45.5% from ¥77,378,908.59 in Q1 2022[17]. - The company did not report any new product developments or market expansion strategies during this quarter[12]. Accounting and Standards - The company adopted new accounting standards starting in 2023, which may impact financial reporting and asset recognition[22].

Dividend Distribution - The company plans to distribute a cash dividend of 2.00 CNY per 10 shares, totaling 61,073,420.00 CNY, which represents 3.31% of the net profit attributable to ordinary shareholders for the year[6]. - In 2022, the total cash dividends distributed amounted to 977,174,720.00 CNY, accounting for 52.98% of the net profit attributable to ordinary shareholders[6]. - The company intends to issue 0.45 bonus shares for every share held, increasing the total share capital to 442,782,295 shares[7]. - The company's total share capital as of December 31, 2022, was 305,367,100 shares, which serves as the basis for the dividend distribution calculations[171]. - The cash dividend distribution for the first half of 2022 was completed by September 30, 2022[170]. - The company's profit distribution plan has been approved by independent directors, ensuring compliance with company regulations and decision-making procedures[171]. Financial Performance - The company's operating revenue for 2022 reached ¥8,348,772,840.84, representing a year-on-year increase of 28.76% compared to ¥6,483,760,507.83 in 2021[23]. - The net profit attributable to shareholders of the listed company was ¥1,844,424,518.46 in 2022, a significant increase of 125.91% from ¥816,452,808.96 in 2021[23]. - The basic earnings per share for 2022 was ¥6.1257, up 122.83% from ¥2.7490 in 2021[24]. - The company's total assets increased by 14.68% to ¥6,513,098,085.61 at the end of 2022, compared to ¥5,679,443,510.79 at the end of 2021[23]. - The company achieved a net cash flow from operating activities of ¥1,773,699,279.71 in 2022, an increase of 78.48% from ¥993,795,032.81 in 2021[23]. - The weighted average return on net assets for 2022 was 60.85%, an increase of 24.17 percentage points from 36.68% in 2021[24]. Risk Management - The company has outlined various risks including safety, environmental, market fluctuations, and raw material price volatility in its management discussion[11]. - The company emphasizes the importance of investor awareness regarding the risks associated with forward-looking statements in the report[8]. - The company faces risks related to safety, environmental protection, industry policies, market fluctuations, and exchange rates[122]. - The company will enhance safety management and conduct comprehensive risk analysis to ensure stable production operations[123]. Research and Development - The company is focusing on innovation by increasing R&D investments in key intermediates, flame retardants, and nano new materials to ensure long-term development[35]. - The total R&D expenditure amounted to 263,536,551.05 yuan, representing 3.16% of total revenue[63]. - Research and development expenses increased by 11.06% to 263.54 million RMB, reflecting the company's commitment to innovation[49]. - The company applied for 29 patents in 2022, including 2 international patents, and received authorization for 15 patents[85]. - The company invested CNY 263.54 million in R&D in 2022, with 13 new projects initiated and 20 ongoing projects, resulting in 14 project outputs and 6 projects carried over to 2023[85]. Environmental Management - The company invested CNY 11,989,000 in environmental protection during the reporting period[183]. - A total of 62 environmental improvement projects were implemented, focusing on VOCs reduction, wastewater reduction, and dust control[184]. - The company achieved compliance with wastewater discharge standards, with COD emissions averaging 283.9 mg/L against a limit of 500 mg/L[187]. - The company maintained stable operation of all environmental protection facilities, ensuring compliance with emission standards[185]. - The company reported a decrease in emissions of major pollutants such as sulfur dioxide and nitrogen oxides compared to the previous year[184]. - The company has not faced any administrative penalties related to environmental issues during the reporting period[193]. Governance and Compliance - The company has established a long-term mechanism to prevent major shareholders from infringing on the interests of the listed company[129]. - The board of directors consists of 9 members, including 3 independent directors, ensuring compliance with governance standards[130]. - The company emphasizes transparency in information disclosure, ensuring all shareholders have equal access to information[132]. - The company has revised its governance structure to ensure compliance with legal requirements and protect shareholder rights, particularly for minority shareholders[128]. Market Expansion and Strategy - The company is focusing on expanding its market presence through precise layout and scientific positioning, aiming to enhance sales scale[36]. - The company is enhancing its marketing strategies to stabilize sales volume and expand the sales area, variety, and volume of formulations[118]. - The company plans to advance the construction of its second and third production bases and implement key projects, including a 100,000-ton intelligent formulation project[113]. - The company is considering strategic acquisitions to enhance its product portfolio, with a budget of $300 million earmarked for potential deals[146]. Leadership and Management - The company has seen leadership changes with Pang Changguo becoming the Chief Engineer in January 2023 after various roles since November 2011[148]. - The company reported a significant leadership presence in the agricultural technology sector, with Zhang Hua as Chairman of multiple subsidiaries since September 2021[149]. - The company has a strong management team with members holding key positions in shareholder units, such as Gu Jian Guo as Deputy Secretary and General Manager since December 2020[149]. - The leadership team has been stable, with many members serving in their roles for several years, ensuring continuity in management[148]. Employee Management - Employee motivation initiatives are being strengthened through stock incentives and positive reinforcement to enhance company cohesion[38]. - The company plans to implement a 40% key position training program and a 20% job rotation plan to cultivate backup talent[169]. - The company is focused on optimizing its salary system and implementing differentiated assessments for marketing and R&D personnel[167]. - A total of 53 young backbone employees were promoted, and 36 key positions were newly appointed during the reporting period[169].

二、 说明会召开的时间、地点 证券代码：600389 证券简称：江山股份 公告编号：临 2023-012 南通江山农药化工股份有限公司 关于召开 2022 年度业绩说明会的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 南通江山农药化工股份有限公司（以下简称"公司"）拟于 2023 年 4 月 18 日发布公司 2022 年度报告，为便于广大投资者更全面深入地了解公司 2022 年度 经营成果、财务状况，公司计划于 2023 年 4 月 21 日下午 15:00-16:00 举行 2022 年度业绩说明会，就投资者关心的问题进行交流。 一、 说明会类型 本次投资者说明会以网络互动形式召开，公司将针对 2022 年度的经营成果 及财务指标的具体情况与投资者进行互动交流和沟通，在信息披露允许的范围内 就投资者普遍关注的问题进行回答。 （一） 会议召开时间：2023 年 04 月 21 日 下午 15:00-16:00 1 会议召开时间：2023 年 4 月 21 日(星期五) 下午 15:00-16:00 会 ...

Financial Performance - The company's operating revenue for Q3 2022 was ¥1,868,864,214.45, representing a year-on-year increase of 13.97%[7] - The net profit attributable to shareholders for Q3 2022 was ¥475,980,633.92, showing a significant increase of 118.61% compared to the same period last year[7] - The net profit attributable to shareholders after deducting non-recurring gains and losses for Q3 2022 was ¥499,767,302.90, reflecting a growth of 133.39% year-on-year[7] - The basic earnings per share for Q3 2022 was ¥1.6026, an increase of 118.61% compared to the same period last year[10] - The total revenue for the first three quarters of 2022 reached ¥7,099,510,918.33, a significant increase from ¥4,793,108,683.01 in the same period of 2021, representing a growth of approximately 48.2%[29] - Operating profit for the third quarter of 2022 was ¥2,025,882,058.11, compared to ¥650,727,484.98 in the third quarter of 2021, indicating a substantial increase of about 210.5%[29] - Net profit attributable to shareholders of the parent company for the third quarter of 2022 was ¥1,688,829,664.35, up from ¥524,707,827.41 in the same quarter of 2021, reflecting a growth of approximately 221.5%[29] - The company reported a net profit margin of approximately 23.7% for the third quarter of 2022, compared to 11.2% in the same quarter of 2021, showing an improvement in profitability[29] Assets and Liabilities - The total assets at the end of the reporting period were ¥6,266,242,445.80, which is a 10.33% increase from the end of the previous year[10] - The company's total assets amounted to approximately RMB 6.27 billion, an increase from RMB 5.68 billion at the end of 2021, representing a growth of about 10.4%[20] - The company's total liabilities reached ¥734,214,394.32, up from ¥478,414,642.00 in the previous year, indicating an increase of about 53.5%[29] - Total current liabilities decreased to approximately RMB 2.45 billion from RMB 2.80 billion, a reduction of about 12.5%[23] Cash Flow - The net cash flow from operating activities for the year-to-date was ¥1,386,220,736.93, representing a year-on-year increase of 162.38%[10] - Cash flow from operating activities for the first three quarters of 2022 was ¥6,437,551,727.79, compared to ¥3,893,577,175.32 in the same period of 2021, reflecting a growth of about 65.5%[31] - The net cash flow from operating activities was 1,386,220,736.93, an increase from 528,335,367.09 in the previous period, reflecting a significant growth[35] - The total cash and cash equivalents at the end of the period reached 1,206,693,104.50, up from 569,009,488.49, indicating improved liquidity[37] Equity and Investments - The company reported a total equity attributable to shareholders of ¥3,079,156,738.63, which is a 31.15% increase compared to the previous year[10] - The total equity attributable to shareholders of the parent company was ¥3,079,156,738.63, compared to ¥2,347,782,338.70 in the previous year, indicating an increase of approximately 31.2%[29] - The company's long-term equity investments rose to RMB 307.19 million from RMB 282.19 million, marking an increase of approximately 8.9%[20] Operational Efficiency - The weighted average return on equity for Q3 2022 was 12.6087%, an increase of 2.9087 percentage points year-on-year[10] - The increase in operating revenue year-to-date was primarily due to the growth in sales prices and quantities of main products[12] - Research and development expenses for the third quarter of 2022 were ¥224,647,587.54, compared to ¥150,498,809.38 in the same quarter of 2021, marking an increase of approximately 49.2%[29] Cash Management - Cash paid for operating activities amounted to 5,158,011,274.56, compared to 3,459,699,940.31, reflecting higher operational costs[35] - The company paid 941,472,629.15 in dividends and interest, significantly higher than 460,670,943.94 in the previous period, reflecting increased shareholder returns[37] - Cash inflow from investment activities totaled 403,722,651.55, down from 641,086,862.48, indicating a decrease in investment returns[35] - The cash outflow for investment activities was 956,145,712.46, compared to 880,478,921.46, indicating increased capital expenditures[35] Other Information - The company has not disclosed any significant new product developments or market expansion strategies during the reporting period[18] - There are no indications of related party transactions among the top ten shareholders[20] - The impact of exchange rate changes on cash and cash equivalents was 943,880.34, a decrease from 5,851,739.58, indicating reduced foreign exchange gains[37]

Financial Performance - The company's operating revenue for the first half of the year reached ¥5,230,646,703.88, representing a 65.87% increase compared to the same period last year[22]. - Net profit attributable to shareholders was ¥1,212,849,030.43, a significant increase of 295.10% year-on-year[22]. - The net cash flow from operating activities was ¥1,073,231,003.12, reflecting a 563.83% increase compared to the previous year[22]. - Basic earnings per share were ¥4.0837, up 295.10% from ¥1.0336 in the same period last year[24]. - The weighted average return on net assets increased to 41.0550%, up 26.4865 percentage points year-on-year[24]. - The gross profit for the first half was 1.817 billion yuan, with an average gross margin rising from 19.73% to 34.75%[41]. - The company's retained earnings increased significantly to CNY 2,781,801,661.95 from CNY 1,568,952,631.52, showing a growth of about 77.1%[191]. Dividend and Shareholder Information - The company plans to distribute a cash dividend of 30.00 CNY (including tax) for every 10 shares, totaling approximately 916.1 million CNY based on a total share capital of 305,367,100 shares as of June 30, 2022[6]. - The total number of ordinary shareholders at the end of the reporting period is 17,171[169]. - The company issued 8,367,100 restricted shares under the 2022 Restricted Stock Incentive Plan, increasing the total shares from 297,000,000 to 305,367,100[167]. - The total number of restricted shares held by the company’s employees under the 2022 stock incentive plan is 8,367,100, with 3,346,840 shares eligible for trading after the lock-up period[175]. Assets and Liabilities - The company's total assets at the end of the reporting period were ¥7,019,559,183.22, a 23.60% increase from the end of the previous year[22]. - Total liabilities reached CNY 3,392,622,719.12, an increase from CNY 3,277,655,341.73, which is a rise of about 3.5%[191]. - Current assets totaled CNY 4,694,178,358.82, compared to CNY 3,374,600,971.95 at the beginning of the period, reflecting an increase of about 39.0%[187]. - Cash and cash equivalents increased to CNY 1,910,616,975.98 from CNY 1,243,083,748.53, representing a growth of about 53.6%[187]. - Accounts receivable grew to CNY 1,294,806,691.94 from CNY 757,900,247.34, reflecting an increase of approximately 70.7%[187]. - Inventory decreased to CNY 636,150,968.94 from CNY 1,034,925,102.33, indicating a decline of about 38.4%[187]. Research and Development - The company continues to focus on the research and development of pesticide products, including glyphosate and other herbicides, with no significant changes in its main business[30]. - Research and development expenses rose by 85.94% to ¥161,937,783.37, up from ¥87,093,399.54 year-on-year, indicating increased investment in innovation[53]. - New product development is on track, with 9 patents applied for during the reporting period, and the creation product JS-T205 has completed process verification[49]. Environmental Management - The company has been recognized as a national clean production demonstration enterprise and a green factory in Jiangsu Province[38]. - The company strictly adhered to pollution discharge management requirements, ensuring all environmental facilities operated within compliance[101]. - The total COD discharge was reported at 265.8 mg/L, significantly below the limit of 500 mg/L[104]. - The company invested approximately 135 million yuan in the construction of a hazardous waste incineration facility, which has commenced trial operations and utilizes advanced technology for enhanced disposal capacity and lower emissions[109]. - The company has implemented 62 environmental enhancement plans with a budget of 120 million yuan, focusing on projects such as deep denitrification of boiler flue gas to improve pollution control capabilities[115]. Governance and Compliance - The board of directors confirmed that all members attended the meeting, ensuring the accuracy and completeness of the semi-annual report[5]. - The semi-annual report has not been audited, but the management has assured the financial report's authenticity and accuracy[5]. - The company has not indicated any changes in its governance structure or significant shareholder changes during the reporting period[18]. - The company has experienced changes in its board and management, including the resignation of key executives and the election of new independent directors[92]. Risks and Challenges - There are no significant risks or violations reported regarding the use of funds by controlling shareholders or related parties[8]. - The company has not faced any major risks that could impact its operations or financial performance[8]. - The company faced risks related to safety, environmental protection, industry policies, market fluctuations, and exchange rates[80]. - The company is exposed to raw material price fluctuations, primarily for coal, yellow phosphorus, salt, methanol, and glycine, which could impact profit margins[85].

Financial Performance - The company's operating revenue for 2021 was approximately ¥6.48 billion, representing a 26.60% increase compared to ¥5.12 billion in 2020[25]. - Net profit attributable to shareholders for 2021 reached approximately ¥816.45 million, a significant increase of 143.76% from ¥334.93 million in 2020[25]. - The net cash flow from operating activities for 2021 was approximately ¥993.80 million, up 40.53% from ¥707.17 million in 2020[25]. - The total assets at the end of 2021 amounted to approximately ¥5.68 billion, reflecting a 23.58% increase from ¥4.60 billion at the end of 2020[25]. - The basic earnings per share for 2021 was ¥2.7490, which is a 143.77% increase compared to ¥1.1277 in 2020[25]. - The weighted average return on equity for 2021 was 36.68%, an increase of 20.38 percentage points from 16.30% in 2020[25]. - The company reported a total of ¥16.37 million in non-recurring gains for 2021, after accounting for tax and minority interests[29]. - The company achieved a total revenue of 6.48 billion RMB, representing a year-on-year increase of 26.6%[50]. - Revenue from pesticide products reached 3.91 billion RMB, up 29.48% year-on-year, contributing significantly to overall growth[56]. Dividends and Profit Distribution - In 2021, Jiangshan Co. distributed cash dividends of 10.00 RMB per 10 shares, totaling 297 million RMB, which accounted for 36.38% of the net profit attributable to ordinary shareholders[6]. - The company does not plan to distribute profits or increase capital reserves at the end of 2021[6]. - The cash dividends distributed in 2021 accounted for 36.38% of the net profit attributable to ordinary shareholders in the consolidated financial statements[196]. - The company has ensured the continuity and stability of its dividend policy while considering the long-term interests of all shareholders[199]. Research and Development - The company invested approximately 237 million yuan in R&D, filing 28 patents, including 19 invention patents[37]. - The company completed the construction of a modular pilot test device with a total investment of 43.2 million yuan by the end of the year[37]. - The company launched 11 new formulation registrations, with 4 products already achieving scale sales[37]. - The company invested CNY 237.30 million in R&D, with 15 new projects initiated, totaling 17 ongoing projects[95]. - The company applied for 28 patents in 2021, with 14 granted, including 1 PCT patent published in the US[95]. Environmental and Safety Initiatives - The company invested approximately ¥15.48 million in safety enhancement projects during 2021, addressing five major safety technical challenges[36]. - The company implemented 38 environmental improvement projects in 2021, with an investment of approximately ¥16.80 million, further solidifying its environmental management foundation[36]. - The company is committed to improving safety and environmental standards by increasing investments and establishing a comprehensive safety management system[124]. - The company has established a comprehensive waste management technology system, recognized as a national clean production demonstration enterprise in 2013[49]. - The company aims to enhance environmental management and reduce risks by strengthening source governance and implementing environmental responsibilities[135]. Governance and Compliance - The company reported a standard unqualified audit opinion from Xinyong Zhonghe Accounting Firm for the fiscal year[5]. - The company has not experienced any non-operational fund occupation by controlling shareholders or related parties[8]. - The company has maintained compliance with decision-making procedures regarding external guarantees[8]. - The company has a robust governance structure and has passed certifications for seven major management systems, enhancing operational efficiency[49]. - The company has established a long-term mechanism to prevent major shareholders from infringing on the interests of the listed company[140]. Market and Strategic Initiatives - The company is actively pursuing new product development and market expansion, focusing on environmentally friendly pesticide solutions[48]. - The company plans to strengthen its marketing team and optimize its domestic and overseas sales networks to steadily increase sales scale[129]. - The company is focusing on high-quality development and innovation in the pesticide industry, aligning with national policies for sustainable growth[80]. - The global pesticide market is expected to maintain a rigid demand due to increasing population and food security concerns, with major markets in Asia-Pacific, Latin America, Europe, and North America[117]. - The company is considering strategic acquisitions to enhance its product portfolio, with a budget of 10 million allocated for this purpose[162]. Challenges and Risks - Jiangshan Co. has detailed risks related to industry policy changes, market fluctuations, raw material price volatility, and environmental factors in its report[8]. - The company faces risks related to safety, environmental regulations, market fluctuations, and exchange rates, which it aims to mitigate through enhanced risk management practices[133]. - The company is exposed to raw material price fluctuations, particularly for coal, yellow phosphorus, salt, methanol, and glycine, which could impact manufacturing costs and gross margins[136]. - The company has significant export operations, and fluctuations in exchange rates against the USD and AUD could affect profitability; measures will be taken to manage currency risk[136]. Human Resources and Training - The company reported a total of 1,822 employees, with 1,407 in the parent company and 415 in major subsidiaries[190]. - The company has established a comprehensive training plan focusing on safety and skill training for grassroots production personnel and management training for technical staff[194]. - A key talent development program was implemented, with 40% of key positions undergoing training and 20% participating in job rotation[194]. - The company has adopted various training methods, including internal training, external training, and industry exchanges, to enhance the effectiveness of skill development[194]. - The company has established a performance-based compensation system, emphasizing skill and position-based salary allocation, and implementing comprehensive performance evaluations[191].

Financial Performance - The company's operating revenue for Q1 2022 was ¥2,719,079,434.12, representing a year-on-year increase of 74.97%[6] - The net profit attributable to shareholders was ¥645,817,160.59, reflecting a significant increase of 452.22% compared to the same period last year[6] - The basic earnings per share for the period was ¥2.1745, which is an increase of 452.22% year-on-year[6] - The company reported a net profit of ¥2,214,769,792.11 for Q1 2022, compared to ¥1,568,952,631.52 in Q1 2021, marking a growth of 41.2%[27] - The net profit for the current period reached CNY 651,775,603.73, a significant increase compared to CNY 121,461,305.26 in the previous period, representing a growth of approximately 436%[30] - Operating profit surged to CNY 771,423,445.71, compared to CNY 144,606,751.85 in the same period last year, indicating a year-over-year increase of about 433%[30] - The total revenue from operating activities was CNY 2,180,216,077.52, compared to CNY 1,122,499,256.66 in the previous year, representing a growth of approximately 94%[37] - The total comprehensive income for the current period was CNY 651,792,919.22, compared to CNY 122,020,895.24 in the previous period, showing a growth of approximately 435%[33] Assets and Liabilities - The total assets at the end of the reporting period amounted to ¥6,238,741,384.76, a growth of 9.85% from the end of the previous year[8] - Current assets totaled ¥3,901,953,309.96 as of March 31, 2022, compared to ¥3,374,600,971.95 at the end of 2021, indicating an increase of 15.6%[21] - Non-current assets amounted to ¥2,336,788,074.80, slightly up from ¥2,304,842,538.84, showing a growth of 1.4%[25] - Total liabilities decreased to ¥3,183,843,200.65 from ¥3,277,655,341.73, a reduction of 2.9%[27] - Shareholders' equity rose to ¥3,054,898,184.11 from ¥2,401,788,169.06, reflecting an increase of 27.2%[27] Cash Flow - The net cash flow from operating activities was ¥348,590,406.32, with no year-on-year comparison available[6] - The cash flow from operating activities showed a net inflow of CNY 348,590,406.32, a turnaround from a net outflow of CNY -77,762,518.43 in the previous period[37] - Cash flow from financing activities totaled $5,822,068.68, compared to $310,165,694.90 in the previous period[39] - Net cash flow from financing activities was $20,461,158.32, a significant improvement from -$9,665,694.90 in the prior period[39] - The net decrease in cash and cash equivalents was -$27,548,495.01, compared to -$309,341,104.37 previously[39] - The ending balance of cash and cash equivalents stood at $1,069,685,675.28, significantly higher than $455,146,805.31 last period[39] Expenses - Total operating costs for Q1 2022 were ¥1,947,969,115.89, up from ¥1,422,334,942.80 in Q1 2021, reflecting a growth of 37.0%[29] - Research and development expenses increased to CNY 77,378,908.59, up from CNY 43,208,304.11, reflecting a growth of approximately 79%[30] - Sales expenses rose sharply to CNY 16,539,468.65, compared to CNY 5,844,361.80, marking an increase of about 183%[30] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 13,500[13] - The weighted average return on equity rose by 18.312 percentage points to 24.182%[6] Market Strategy - The increase in operating revenue was primarily driven by product price growth[10] - The company plans to continue expanding its market presence and investing in new product development to sustain growth[29] Other Financial Metrics - The company reported non-recurring gains and losses totaling ¥8,034,255.94 for the period[9] - The company reported investment income of CNY 17,773,489.11, up from CNY 11,077,694.52, indicating an increase of about 60%[30] - The company incurred a financial expense of CNY 6,777,646.93, compared to a financial income of CNY -54,126.95 in the previous period, indicating a significant shift in financial performance[30]

Financial Performance - Revenue for the third quarter reached ¥1,639,718,703.23, an increase of 55.15% compared to the same period last year[7] - Net profit attributable to shareholders was ¥217,734,266.20, reflecting a significant increase of 340.58% year-over-year[7] - Basic earnings per share for the quarter were ¥0.7331, up 340.58% from the previous year[10] - The weighted average return on equity increased by 7.41 percentage points to 9.70% for the quarter[10] - The net profit attributable to shareholders for the year-to-date reached ¥524,707,827.41, a 101.10% increase compared to the same period last year[7] - The company reported a net profit excluding non-recurring gains and losses of ¥512,535,626.63, up 97.17% year-over-year[7] - Total operating revenue for the first three quarters of 2021 reached CNY 4,793,108,683.01, an increase from CNY 3,767,513,901.78 in the same period of 2020, representing a growth of approximately 27.2%[30] - Net profit attributable to shareholders of the parent company for the third quarter of 2021 was CNY 524,707,827.41, compared to CNY 260,912,593.24 in the same quarter of 2020, reflecting a year-over-year increase of about 101.0%[33] - The company reported a profit before tax of CNY 640,076,928.50 for the third quarter of 2021, compared to CNY 314,298,910.63 in the same quarter of 2020, indicating a significant increase of approximately 103.5%[33] - The total comprehensive income for the third quarter of 2021 was impacted by a decrease in other comprehensive income, which was CNY -1,028,516.22 compared to CNY -368,279.42 in the same quarter of 2020[33] - The total comprehensive income for the period reached ¥534,899,933.17, a significant increase from ¥270,055,965.37 in the previous year, representing a growth of approximately 97.8%[35] Assets and Liabilities - Total assets at the end of the quarter amounted to ¥4,961,800,754.18, representing a 7.97% increase from the end of the previous year[10] - Total assets reached ¥4,961,800,754.18, up from ¥4,595,614,577.48, marking an increase of about 7.9%[25] - Total liabilities as of the end of the reporting period amounted to CNY 2,851,189,702.20, up from CNY 2,563,044,964.66 in the previous year, indicating a growth of approximately 11.3%[30] - The company's total equity attributable to shareholders reached CNY 2,056,450,830.80, compared to CNY 1,978,368,884.15 in the previous year, marking an increase of about 3.9%[30] - The total current assets as of September 30, 2021, amounted to ¥2,716,383,102.14, an increase from ¥2,459,341,987.82 as of December 31, 2020, reflecting a growth of approximately 10.5%[21] - Cash and cash equivalents decreased to ¥728,391,205.10 from ¥847,842,335.27, representing a decline of about 14.1%[21] - Accounts receivable increased to ¥868,003,649.44 from ¥752,736,029.34, showing a growth of approximately 15.3%[21] - Inventory rose to ¥567,520,076.16 compared to ¥524,522,706.38, indicating an increase of around 8.2%[25] - Short-term borrowings decreased significantly to ¥300,500,000.00 from ¥528,410,362.47, a reduction of approximately 43.2%[25] - The company reported a notable increase in accounts payable, which rose to ¥623,218,096.03 from ¥508,215,210.17, reflecting a growth of about 22.7%[25] Cash Flow - Cash flow from operating activities for the year-to-date was ¥528,335,367.09, an increase of 61.14%[10] - Cash flow from operating activities generated a net amount of ¥528,335,367.09, up from ¥327,873,401.06, reflecting a growth of about 61%[39] - Cash inflow from operating activities totaled ¥3,988,035,307.40, compared to ¥3,160,143,213.42 in the previous year, marking an increase of approximately 26%[39] - The company recorded cash outflow from investing activities of ¥880,478,921.46, significantly higher than ¥149,184,073.31 in the previous year, indicating increased investment activity[40] - The net cash flow from financing activities was -¥490,273,468.88, compared to -¥345,655,348.56 in the previous year, showing a deeper cash outflow[40] - The cash and cash equivalents at the end of the period amounted to ¥569,009,488.49, an increase from ¥431,227,343.08 in the previous year[40] - The company received cash from investment recovery totaling ¥620,000,000.00, which was not recorded in the previous year[39] - The total cash inflow from investment activities was ¥641,086,862.48, a substantial increase from ¥20,126,365.32 in the previous year[39] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 13,950[15] - The largest shareholder, Nantong Industrial Holding Group Co., Ltd., holds 29.30% of the shares, totaling 87,019,707 shares[15] Research and Development - Research and development expenses for the first three quarters of 2021 were CNY 150,498,809.38, compared to CNY 138,287,928.03 in the same period of 2020, showing an increase of approximately 8.8%[30] - The company has not disclosed any new product developments or market expansion strategies during this reporting period[21] - There are no significant mergers or acquisitions reported in the current financial period[21] Employee Compensation - The company paid ¥227,218,146.12 in employee compensation, up from ¥195,176,243.77, reflecting a growth of approximately 16%[39] - The company has a total of approximately $90.58 million in employee compensation payable, reflecting its commitment to workforce management[47]

Financial Performance - The company's operating revenue for the first half of 2021 reached ¥3,153,389,979.78, representing a 16.33% increase compared to ¥2,710,670,937.40 in the same period last year[20] - Net profit attributable to shareholders for the first half of 2021 was ¥306,973,561.21, a 45.15% increase from ¥211,492,305.67 in the previous year[20] - The net profit after deducting non-recurring gains and losses was ¥298,403,487.42, up 40.22% from ¥212,811,670.18 year-on-year[20] - Basic earnings per share for the first half of 2021 were ¥1.0336, a 45.15% increase from ¥0.7121 in the same period last year[20] - The gross profit margin increased from 18.05% to 19.73%, with pesticide products contributing a gross profit of CNY 422 million, up 44% year-on-year[37] - The total operating revenue for the first half of 2021 was RMB 3,153,389,979.78, an increase from RMB 2,710,670,937.40 in the same period of 2020, representing a growth of approximately 16.3%[163] - The net profit for the first half of 2021 was RMB 321,179,799.68, up from RMB 221,552,910.24 in the same period of 2020, reflecting a growth of approximately 45%[166] Cash Flow and Assets - The net cash flow from operating activities decreased by 36.94% to ¥161,673,566.99 from ¥256,388,776.34 in the same period last year[20] - The company's cash and cash equivalents decreased by 39.65% from the previous year, totaling ¥511,679,127.37, which accounts for 11.36% of total assets[47] - The company's total assets as of the end of the reporting period were ¥4,502,454,006.08, a decrease of 2.03% from ¥4,595,614,577.48 at the end of the previous year[20] - The company's cash and cash equivalents were reported at 511,679,127.37 RMB, down from 847,842,335.27 RMB at the end of 2020[151] - The total current assets as of June 30, 2021, amounted to 2,304,831,520.15 RMB, a decrease from 2,459,341,987.82 RMB at the end of 2020[151] Investments and R&D - The company has undertaken over 10 national science and technology projects, demonstrating its strong research and development capabilities[32] - The company has initiated 17 new R&D projects and is continuing research on three new flame retardant products, with 20 new formulation studies for high-end formulations initiated at the beginning of the year[42] - Research and development expenses for the first half of 2021 were RMB 87,093,399.54, down from RMB 103,601,859.31 in the same period of 2020, indicating a decrease of about 16%[165] Market and Industry Position - The global agricultural chemical market is in an upward cycle, driven by increased demand and rising commodity prices[27] - The company has been recognized as a national high-tech enterprise and a pilot innovative enterprise in Jiangsu Province[32] - The company actively promotes safety management and is one of the first 12 pesticide production enterprises recognized for HSE management in China[33] Environmental and Safety Management - The company has implemented 17 out of 33 environmental improvement measures aimed at reducing VOC emissions and enhancing waste management systems[79] - The company continues to meet environmental standards, with all pollution control facilities operating stably and no exceedances reported[80] - The average concentration of COD in wastewater discharge was 24 mg/L, well below the limit of 500 mg/L, with no exceedances reported[84] Shareholder and Corporate Governance - The company committed to resolving competition issues with its controlling shareholder by integrating its subsidiary's operations within 12 months, as per regulatory requirements[96] - The company has established strict guidelines to regulate related party transactions, ensuring compliance with legal and regulatory standards[105] - The company has committed to maintaining the independence of its operational decisions and protecting the interests of minority shareholders[102] Financial Stability and Liabilities - The company's short-term borrowings decreased by 43.13% to ¥300,500,000.00, representing 6.67% of total liabilities[47] - The company's long-term borrowings increased by 253.91% to ¥302,463,296.70, accounting for 6.72% of total liabilities[47] - The total liabilities decreased to RMB 2,278,096,648.16 from RMB 2,397,902,938.72, showing a reduction of about 5%[163] Future Plans and Strategies - The company plans to optimize product structure and expand product lines to enhance profitability amid market competition and price decline risks[61] - The company plans to continue focusing on market expansion and new product development to drive future growth[162]

Financial Performance - The company's operating revenue for 2020 was CNY 5,121,357,779.17, representing a 7.11% increase from CNY 4,781,182,239.01 in 2019[21] - The net profit attributable to shareholders of the listed company was CNY 334,934,906.61, an increase of 11.62% compared to CNY 300,061,162.27 in 2019[21] - The net cash flow from operating activities reached CNY 707,172,745.86, showing a significant increase of 72.87% from CNY 409,081,587.64 in 2019[21] - The total assets of the company at the end of 2020 were CNY 4,595,614,577.48, a 6.72% increase from CNY 4,306,243,931.02 at the end of 2019[21] - The net assets attributable to shareholders of the listed company decreased by 1.82% to CNY 1,978,368,884.15 from CNY 2,015,003,957.26 in 2019[21] - Basic earnings per share for 2020 was CNY 1.1277, an increase of 11.62% compared to CNY 1.0103 in 2019[22] - The weighted average return on equity rose to 16.30% in 2020, up 0.68 percentage points from 15.62% in 2019[22] Revenue and Sales - Total revenue for the first quarter of 2020 was CNY 1,243,898,295.96, while the second quarter revenue was CNY 1,466,772,641.44[25] - Net profit attributable to shareholders for the second quarter of 2020 was CNY 113,668,863.78, showing an increase from CNY 97,823,441.89 in the first quarter[25] - Revenue from pesticide products reached CNY 3.017 billion, an increase of CNY 238 million, with a growth rate of 8.58%[50] - The revenue from domestic sales reached ¥3,622,346,639.53, reflecting a 16.72% increase compared to the previous year[58] - The revenue from the chemical segment decreased by 4.57% year-on-year, with a gross profit margin of 24.96%[58] - The company’s insecticides, including dichlorvos and carbofuran, utilize clean production processes, ensuring high product quality and stability[89] Dividends and Shareholder Returns - The company plans to distribute a cash dividend of CNY 5.00 per 10 shares, totaling CNY 148,500,000.00, subject to approval at the annual shareholders' meeting[6] - The company distributed a cash dividend of 3.10 RMB per 10 shares for the 2019 fiscal year, totaling 92,070,000 RMB, and a cash dividend of 10.00 RMB per 10 shares for the first half of 2020, totaling 297,000,000 RMB[140] - In 2020, the company reported a net profit attributable to ordinary shareholders of 334,934,906.60 RMB, with a cash dividend payout ratio of 44.34% for the full year and 88.67% for the first half[141] Operational Efficiency and Costs - The company reported a significant decrease in sales expenses by 59.86%, attributed to the adjustment of product transportation costs to operating costs under the new revenue recognition standards[54] - The company plans to optimize its product structure and increase production capacity utilization to reduce manufacturing costs[135] - The company has adjusted its strategy to enhance production efficiency and reduce costs while expanding the sales of chemical intermediates to improve economic benefits[90] Research and Development - The company invested CNY 169.38 million in R&D in 2020, with 15 new projects initiated and 24 ongoing projects[97] - The number of R&D personnel was 471, making up 27.48% of the total workforce[73] - The company developed 15 new formulation products, with 8 completing field trials and 10 ready for sale, while initiating 15 new domestic registrations and 56 new international registrations[98] Environmental Management - The company has implemented over 60 environmental improvement projects, focusing on VOCs reduction and dust control, and has been recognized as a "Green Factory" in Jiangsu Province[196] - The company has maintained compliance with environmental discharge standards, with no incidents of exceeding discharge limits reported[196] - The company has committed to a circular economy development model, aiming to reduce emissions and enhance resource utilization[196] Risk Management - The company has identified risks related to industry policy changes, market fluctuations, raw material price volatility, and environmental regulations[8] - The company emphasizes the importance of investor awareness regarding the risks associated with forward-looking statements in the report[7] - The company faces risks from market fluctuations in the pesticide industry, including increased competition and potential price declines[136] Strategic Initiatives - The company is actively pursuing strategic collaborations with key clients to optimize customer structure and enhance operational efficiency[46] - The company aims to enhance its research and development capabilities and improve resource utilization to form a competitive product series with stable profitability[128] - The company plans to implement differentiated marketing strategies and optimize its domestic and overseas sales networks to achieve annual marketing goals[130] Corporate Governance - The company has maintained a standard unqualified audit report from its accounting firm, indicating the accuracy and completeness of its financial statements[5] - The company guarantees compliance with laws and regulations, ensuring that it will not exploit its shareholder position for improper benefits or engage in actions detrimental to the listed company and its minority shareholders[147] - The company has not reported any major accounting errors or corrections during the reporting period[161]